| Amanda Nicole Kinney, | |
|
525 Metro Pl N Ste 100, Dublin, OH 43017-5343 | |
| (614) 339-1649 | |
| Not Available |
| Full Name | Amanda Nicole Kinney |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 4 Years |
| Location | 525 Metro Pl N Ste 100, Dublin, Ohio |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083243992 | NPI | - | NPPES |
| 2910854 | Medicaid | OH |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Viaquest Psychiatric And Behavioral Solutions Llc | 1153358486 | 63 |
News Archive
GE Healthcare announced today FDA 510(k) clearance of its latest Brivo Plus C-arm, now available in the US. With legacy OEC image quality and ease-of-use, the affordability and reliability of this new Brivo C-arm will offer a high quality, affordable option for basic surgical imaging.
A team of Swedish scientists have used national registries of more than 3.4 million Swedes aged 40 to 80 to study the association between dog ownership and cardiovascular health.
Neoprobe Corporation, a diversified developer of innovative oncology surgical and diagnostic products, announced today that it completed the previously announced sale of its neoprobe GDS line of gamma detection device systems to Devicor Medical Products, Inc. for $30 million in upfront consideration, plus up to an additional $20 million in royalties based on Devicor's achievement of certain revenue milestones.
Johnson & Johnson has announced the recall of its entire U.S. supply of infants' Tylenol—about 574,000 bottles—due to a design flaw. The flaw involved bottles of grape-flavoured infants' Tylenol, which had only just returned to shelves in November announced J&J last Friday.
Now families children with fragile X syndrome may have a chance of earlier detection and intervention. The Murdoch Children's Research Institute breakthrough could allow newborn screening of the world's most common cause of inherited developmental disability. The research findings were published in the journal Clinical Chemistry.
› Verified 3 days ago
| Entity Name | Viaquest Psychiatric & Behavioral Solutions Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942451216 PECOS PAC ID: 1153358486 Enrollment ID: O20120926000142 |
News Archive
GE Healthcare announced today FDA 510(k) clearance of its latest Brivo Plus C-arm, now available in the US. With legacy OEC image quality and ease-of-use, the affordability and reliability of this new Brivo C-arm will offer a high quality, affordable option for basic surgical imaging.
A team of Swedish scientists have used national registries of more than 3.4 million Swedes aged 40 to 80 to study the association between dog ownership and cardiovascular health.
Neoprobe Corporation, a diversified developer of innovative oncology surgical and diagnostic products, announced today that it completed the previously announced sale of its neoprobe GDS line of gamma detection device systems to Devicor Medical Products, Inc. for $30 million in upfront consideration, plus up to an additional $20 million in royalties based on Devicor's achievement of certain revenue milestones.
Johnson & Johnson has announced the recall of its entire U.S. supply of infants' Tylenol—about 574,000 bottles—due to a design flaw. The flaw involved bottles of grape-flavoured infants' Tylenol, which had only just returned to shelves in November announced J&J last Friday.
Now families children with fragile X syndrome may have a chance of earlier detection and intervention. The Murdoch Children's Research Institute breakthrough could allow newborn screening of the world's most common cause of inherited developmental disability. The research findings were published in the journal Clinical Chemistry.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Amanda Nicole Kinney, 2458 Mczand Blvd, Grove City, OH 43123-1461 Ph: (614) 517-4486 | Amanda Nicole Kinney, 525 Metro Pl N Ste 100, Dublin, OH 43017-5343 Ph: (614) 339-1649 |
News Archive
GE Healthcare announced today FDA 510(k) clearance of its latest Brivo Plus C-arm, now available in the US. With legacy OEC image quality and ease-of-use, the affordability and reliability of this new Brivo C-arm will offer a high quality, affordable option for basic surgical imaging.
A team of Swedish scientists have used national registries of more than 3.4 million Swedes aged 40 to 80 to study the association between dog ownership and cardiovascular health.
Neoprobe Corporation, a diversified developer of innovative oncology surgical and diagnostic products, announced today that it completed the previously announced sale of its neoprobe GDS line of gamma detection device systems to Devicor Medical Products, Inc. for $30 million in upfront consideration, plus up to an additional $20 million in royalties based on Devicor's achievement of certain revenue milestones.
Johnson & Johnson has announced the recall of its entire U.S. supply of infants' Tylenol—about 574,000 bottles—due to a design flaw. The flaw involved bottles of grape-flavoured infants' Tylenol, which had only just returned to shelves in November announced J&J last Friday.
Now families children with fragile X syndrome may have a chance of earlier detection and intervention. The Murdoch Children's Research Institute breakthrough could allow newborn screening of the world's most common cause of inherited developmental disability. The research findings were published in the journal Clinical Chemistry.
› Verified 3 days ago